NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...

Despite being a CEO, I'm an introvert, and some of the most joyful experiences of my life have been locked away inventing algorithms. Software development mostly consists of messy glue and data pipes ...